Old Web
English
Sign In
Acemap
>
authorDetail
>
N. Ravenni
N. Ravenni
ETH Zurich
Clinical trial
Rheumatoid arthritis
Tolerability
Medicine
Dose
3
Papers
29
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
AB0364 A Novel Approach for Rheumatoid Arthritis: Results of The Ongoing Clinical Trials with The Fully Human Immunocytokine Dekavil (F8-IL10)
2016
Annals of the Rheumatic Diseases
Mauro Galeazzi
Reinhard E. Voll
Gian Domenico Sebastiani
Laura Bazzichi
Ombretta Viapiana
J. Dudler
Piercarlo Sarzi-Puttini
Enrico Selvi
Annamaria Iuliano
M Pedretti
L. Giovannoni
I. Bindi
C. Bettini
N. Ravenni
J Wilton
P. Zufferey
G. Ferraccioli
R. Caporali
Christof Specker
J. Wollenhaupt
Dario Neri
Show All
Source
Cite
Save
Citations (0)
SAT0196 Dekavil (F8-IL10), A Novel Therapeutic Approach for Rheumatoid Arthritis: Ongoing Phase IB Clinical Trial Results
2015
Annals of the Rheumatic Diseases
Mauro Galeazzi
Gian Domenico Sebastiani
Laura Bazzichi
E. Garcia Gonzalez
N. Ravenni
L. Giovannoni
J Wilton
Enrico Selvi
Marco Bardelli
C. Baldi
Annamaria Iuliano
G. Minisola
R. Caporali
Stefano Bombardieri
Dario Neri
Show All
Source
Cite
Save
Citations (4)
A phase IB clinical trial with Dekavil (F8-IL10), an immunoregulatory 'armed antibody' for the treatment of rheumatoid arthritis, used in combination wiIh methotrexate
2014
Israel Medical Association Journal
Mauro Galeazzi
Laura Bazzichi
Gian Domenico Sebastiani
Dario Neri
García E
N. Ravenni
L. Giovannoni
J Wilton
Marco Bardelli
C. Baldi
Enrico Selvi
Annamaria Iuliano
G. Minisola
Roberto Caporali
Elena Prisco
Stefano Bombardieri
Show All
Source
Cite
Save
Citations (25)
1